Noris Marina, Perico Norberto, Remuzzi Giuseppe
Laboratory of Immunology and Genetics of Transplantation and Rare Diseases, Mario Negri Institute for Pharmacological Research, Bergamo, Italy.
Nat Clin Pract Nephrol. 2005 Dec;1(2):98-114; quiz 120. doi: 10.1038/ncpneph0035.
Pre-eclampsia, a syndrome of pregnant women, is one of the leading causes of maternal and fetal morbidity and mortality. Despite active research, the etiology of this disorder remains an enigma. Recent work has, however, provided promising explanations for the causation of the disorder and some of its phenotypes. Evidence indicates that the symptoms of hypertension and proteinuria, upon which the diagnosis of pre-eclampsia is based, have several underlying causes. Nevertheless, the treatment of pre-eclampsia has not changed significantly in over 50 years. This review describes the most recent insights into the pathophysiology of pre-eclampsia from both basic and clinical research, and attempts to provide a unifying hypothesis to reconcile the abnormalities at the feto-placental level and the clinical features of the maternal syndrome. The novel findings outlined in this review provide a rationale for potential future prophylactic and therapeutic interventions for pre-eclampsia.
子痫前期是一种孕妇综合征,是孕产妇和胎儿发病及死亡的主要原因之一。尽管进行了积极的研究,但这种疾病的病因仍然是个谜。然而,最近的研究工作为该疾病的病因及其一些表型提供了有希望的解释。有证据表明,子痫前期诊断所依据的高血压和蛋白尿症状有多种潜在原因。尽管如此,子痫前期的治疗在50多年来并没有显著改变。本综述描述了基础研究和临床研究对子痫前期病理生理学的最新见解,并试图提供一个统一的假说,以协调胎儿-胎盘水平的异常与母体综合征的临床特征。本综述中概述的新发现为未来子痫前期的潜在预防和治疗干预提供了理论依据。